Latest News & Features
Refine Search
Americas
Generic drug maker Amneal has secured a finding of non-infringement in a Hatch-Waxman case over kidney disease drug Sensipar (cinacalcet hydrochloride). 1 August 2018
Americas
Morgan Lewis & Bockius has boosted its IP litigation team with the addition of seven partners from McDermott Will & Emery who have experience in the life sciences and technology industries. 1 August 2018
Biotechnology
Manuel Salmeron-Sanchez and Matthew Dalby were selected in the LSIPR 50 2018 publication for their influence on the life sciences industry. They featured in the business and innovation section, as LSIPR reports. 1 August 2018
Americas
US-based pharmaceutical company Pfizer today reported an increase in year-on-year revenue for the second quarter but projected nearly a $2 billion loss in 2018 due to patent expirations. 31 July 2018
Europe
Michel Sidibé was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the government and policy section, as LSIPR reports. 31 July 2018
Big Pharma
IP service provider Questel has acquired France-based Expernova, a company specialising in scientific big data. 30 July 2018
Americas
Sandoz has agreed to postpone its generic version of a cataract surgery drug made by biopharmaceutical company Omeros, ending a patent infringement lawsuit between the two in Delaware. 30 July 2018
Biotechnology
A ruling handed down last week by the Court of Justice of the European Union could stifle innovation in the gene-editing field, causing Europe to lag behind the rest of the world, commentators say. 30 July 2018
Americas
Vanessa Yen has joined King & Spalding's trial and global disputes practice group as a partner after leaving Paul Hastings. 30 July 2018
Asia
Naoko Munakata was selected in the LSIPR 50 2018 publication for her influence on the life sciences industry. She featured in the government and policy section, as LSIPR reports. 30 July 2018